We studied the effects of oral administration of RU38486, a potent and selective glucocorticoid antagonist, on muscle weight, non-collagen protein content, and selected enzyme activities (choline acetyltransferase, glucose 6phosphate dehydrogenase, and glutamine synthetase) following denervation of rat skeletal muscle. Neither decreases in muscle weight, protein content, and choline acetyl transferase activity, nor increases in the activities of glucose 6-phosphate dehydrogenase and glutamine synthetase were affected by RU38486.
INTRODUCTION
The mechanism by which denervation causes atrophy of skeletal muscle is not known. Almon (1980, 1981) proposed an intriguing hypothesis, according to which enhanced sensitivity of muscle to endogenous glucocorticoids might play a role in the promotion of denervation atrophy.
This hypothesis was based upon the demonstration of strikingly increased cytoplasmic gl ucocorticoid receptor binding after denervation (reviewed in Karpati, 1984) . Indeed, DuBois and Almon noted enhanced cytoplasmic glucocorticoid receptor binding in a number of other causes of atrophy including disuse (1980), murine (1984b) and avian (1982) dystrophies, and atrophy of the levator ani muscle following orchiectomy (19S4a); they suggested that atrophy, irrespective of cause, is related to gl ucocorticoid actions.
It is well-established that exogenous glucocorticoids can cause pronounced muscle atrophy (Koski et al ., 1974; Kelly et al ., 1986; Kona.gaya et al... 1986a) . The hypothesis of DuBois and Almon is therefore of interest and warrants investigation, especially because of the possibility of treating denervated.mus.cles with gl ucocorticoid antagonists^ We (Konagaya et al.,
. .-;. .... ,. 1986a.)..were, .able, to prevent, to a significant extent, glucocorticoid-.mediated muscle atrophy in the rat using RU38486 (Philibert, 1984) , a potent and selective gl ucocorticoid antagonist. Support for the hypothesis of DuBois and Almon was provided by the ability of RU38486 to prevent, to a significant extent, gonadectomy-mediated atrophy of the levator ani muscle (Konagaya and Max, 1986) . We have now used RU38485 to assess whether chronic blockade of gl ucocorticoid receptors can influence the course of muscle atrophy followinĝ enervation. V.'e assessed choline acetyl transf erase and glucose 6-phosphate dehydrooenase activities because they are ore-and post-synaptic biochemical indie-'-:f ry.-scle denervation (Wagner and Max, 1979; Max et al., 1931; 
1982).
We studied glutamine synthetase because 1) its activity is enhanced following denervation (Konagaya et al.. 1986b) , 2) it is involved in mobilization of ami no acids from muscle proteins (Goldberg and Chang, 1979) , and 3) it may be an important index of muscle wasting (Max et al., 1986; Max and Silbergeld, 1986) . Further, glutamine synthetase is induced in muscle by glucocorticoids (Smith et al., 1984; King et al., 1983; Max et al., 1986) . of muscle .glucocorti.coid. receptors., (Konagaya et_aj_., 19.86), .At. 2 and 7 days following denervation, rats were decapitated and denervated and contra!ateral control extensor digitorum longus and plantaris muscles were removed and weighed. The extensor digitorum longus muscle was assayed for choline acetyltransf erase (Max et al_., 1982; Fonnum, 1975) and glucose 5-phosphate dehydrogenase activities (Max _et al_., 1931; Schaerf _et aj_., 1982) as described.
MATERIALS AND METHODS
Plantaris muscles were used for determination of glutamine synthetase activity as described (Rowe, 1985; Smith et al.. 1984 ), using 5 roM -" -"--rte -:s substrate. Both muscles were used to provide sufficient material f or the assays.
ORIGINAL PAGE IS OE P.OOR QUALITY Non-collagen protein was assayed as described (Rifenberick et al., 1974) . Protein in supernatant fractions was determined by the method of Lowry et al. (1951) . .
Statistical analyses were made with a paired t-test.
RESULTS
As expected, denervated muscles lost weight. Seven days after neurotomy, denervated extensor digitorum longus muscles weighed 70% of the contra! ateral control muscle, while denervated plantaris muscles weighed 75% of the central ateral control muscle ( Table 1) . Losses of muscle wet weight were reflected in corresponding losses of non'-coll agen protein, (Table 1) . Glucose 5-phosphate dehydrogenase activity increased 2-fold in denervated extensor digitoruni longus muscles, as expected (V.'agner and Max, 1979} (Table 2) .
Choline acetyl transferase activity in extensor digitorum longus muscles declined to about 25% of control (Table 2) . Glutamine synthetase activity in plantaris muscles increased 5.5-fold 8 days after denervation (Table 1) . None of these changes was altered by administration'of RU38486 (Tables 1 and 2 (Max et al ., 1981) decreased, glucose 6-phosphate dehydrogenase (Max et al., 1981) and glutamine synthetase (Konagaya et aj_., 1986b), biochemical markers of post-synaptic (i.e., muscle) integrity increased, and muscle weight and protein content decreased. Concurrent treatment with RU38485 had no effect on the progression of these alterations following denervation. These data do not support the hypothesis that denervation-mediated muscular atrophy results from receptormediated gl ucocorticoid action (Karpati, 1984) . Tremblay et al. (1985) ORIGINAL' PAGE IS. OF POOR compared denervation atrophy in adrenalectomized rats with controls; they found no effect of adrenalectomy in denervation atrophy. Thus, we have confirmed and extended the conclusions of Tremblay et al. (1986) by using a potent glucocorticoid receptor blocker, RU38486, and by measuring the biochemical indices noted above.
We consider glutamine synthetase to be a valuable marker in the present work because its activity is enhanced in muscle following denervation (Konagaya et al., 1986b) between normal and suspended rats. Jaspers and Tischler (1986) concluded that elevation of circulating gl ucocorti coi ds is unlikely to be solely responsible for muscle atrophy secondary to reduced activity, but that catabolic levels of gl ucocorticoids could alter the response of muscle to unloading. RU38486 has been shown to be effective in treating a patient with Cushing's syndrome (Nieman et al_., 1985) . Unfortunately, it seems not to be effective in preventing denarvati on-n?edi ated effects on muscle. The significance of the interesting increase in glucocorticoid receptor binding in denervated and disused muscles Almon, 1980, 1981) 3.30 ± 0.38 ** 29.0 ± 9.1** 2.99 ± 1.25 ** Data are means ± $D,' n = 7. Rats were decapitated and muscles removed 8 days post-denervation. Glucose 6-phosphate dehydrogenase and choline acetyltransferase activities were assayed in extensor digitorum muscles. Glutamine synthetase activity was assayed in plantaris muscles. RU38486 was given orally at 50 mg/kg. ';:
i.
Significantly different from untreated contra! ateral control, p < 0.01; : **Significantly different from contralateral control + RU38486, p < 0.01.
There were no significant differences between untreated and RU38486-treated groups.
Experimental procedures are described in the text.
